$508 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 109 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VIR | Exit | VIR BIOTECHNOLOGY | $0 | – | -4,200 | -100.0% | -0.02% | – |
| RARE | Exit | ULTRAGENYX PHARMAC | $0 | – | -4,300 | -100.0% | -0.05% | – |
| MREO | Exit | MEREO BIOPHARMA GRads | $0 | – | -385,000 | -100.0% | -0.09% | – |
| TALS | Exit | TALARIS THERAPEUTI | $0 | – | -228,624 | -100.0% | -0.21% | – |
| Exit | EXSCIENTIA PLCads | $0 | – | -201,388 | -100.0% | -0.44% | – | |
| MRVI | Exit | MARAVAI LIFESCIENCES | $0 | – | -89,250 | -100.0% | -0.51% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -131,757 | -100.0% | -0.55% | – |
| ITOS | Exit | ITEOS THERAPEUTICS | $0 | – | -147,900 | -100.0% | -0.61% | – |
| AVTE | Exit | AEROVATE THERAPEUT | $0 | – | -196,038 | -100.0% | -0.62% | – |
| CNVY | Exit | CONVEY HEALTH SOL HL | $0 | – | -400,000 | -100.0% | -0.84% | – |
| TNDM | Exit | TANDEM DIABETES CARE | $0 | – | -105,763 | -100.0% | -1.26% | – |
| TPTX | Exit | TURNING POINT THERAP | $0 | – | -90,000 | -100.0% | -1.36% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL | $0 | – | -63,150 | -100.0% | -1.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.